Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-09

FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA granted supplemental approval for Octreotide Acetate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)